Towercrest Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Towercrest Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,163	Closed	-$1.33M	–	106
2024 Q3	$1.33M	Hold	9,163	–	–	0.22%	47
2024 Q2	$1.26M	Sell	9,163 -5,450	-37%	-$728K	0.21%	47
2024 Q1	$2.01M	Sell	14,613 -5	-0%	-$683	0.34%	43
2023 Q4	$1.99M	Hold	14,618	–	–	0.36%	43
2023 Q3	$1.79M	Sell	14,618 -3,260	-18%	-$415K	0.35%	45
2023 Q2	$2.27M	Hold	17,878	–	–	0.42%	41
2023 Q1	$2.31M	Hold	17,878	–	–	0.48%	38
2022 Q4	$2.35M	Sell	17,878 -427	-2%	-$55.2K	0.52%	37
2022 Q3	$2.14M	Hold	18,305	–	–	0.5%	38
2022 Q2	$2.15M	Hold	18,305	–	–	0.48%	36
2022 Q1	$2.38M	Hold	18,305	–	–	0.47%	38
2021 Q4	$2.79M	Hold	18,305	–	–	0.51%	35
2021 Q3	$2.96M	Hold	18,305	–	–	0.56%	35
2021 Q2	$3M	Buy	18,305 +3,687	+25%	+$568K	0.58%	34
2021 Q1	$2.2M	Hold	14,618	–	–	0.47%	35
2020 Q4	$2.21M	Hold	14,618	–	–	0.5%	36
2020 Q3	$1.98M	Hold	14,618	–	–	0.49%	35
2020 Q2	$2M	Sell	14,618 -1,000	-6%	-$127K	0.52%	35
2020 Q1	$1.68M	Buy	15,618 +1,000	+7%	+$115K	0.51%	35
2019 Q4	$1.76M	Sell	14,618 -500	-3%	-$55.8K	0.45%	37
2019 Q3	$1.5M	Hold	15,118	–	–	0.42%	37
2019 Q2	$1.65M	Sell	15,118 -1,499	-9%	-$159K	0.47%	36
2019 Q1	$1.86M	Sell	16,617 -4,746	-22%	-$521K	0.54%	34
2018 Q4	$2.06M	Buy	21,363 +6,500	+44%	+$690K	0.66%	35
2018 Q3	$1.81M	Buy	+14,863	New	+$1.75M	0.54%	39

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Towercrest Capital Management's IBB Position: Q4 2024 in Review

Towercrest Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 9,163 shares — an estimated $1.33M sold.

Towercrest Capital Management first reported a position in IBB in Q3 2018 and held it in 25 quarters. The position peaked at $3M in Q2 2021. 875 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

Towercrest Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
Towercrest Capital Management sold 9,163 iShares Biotechnology ETF shares in Q4 2024, an estimated $1.33M.
Towercrest Capital Management first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 25 quarters.
Towercrest Capital Management's iShares Biotechnology ETF position peaked at $3M in Q2 2021.
875 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Towercrest Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.